(465) An open-label, multicenter study of the safety of twice daily oxycodone hydrochloride controlled-release tablets in opioid experienced children from ages 6 to 16 years old, inclusive, with moderate to severe malignant and/or nonmalignant pain requiring opioid analgesics
2003 ◽
Vol 9
(3)
◽
pp. 223-231
◽
2007 ◽
Vol 1
(S1)
◽
pp. 41-47
◽
2007 ◽
Vol 27
(4)
◽
pp. 259-267
◽
2021 ◽
Vol 5
(3)
◽
pp. 249-253
Keyword(s):